Iodine or Not (IoN) for Low-risk Differentiated Thyroid Cancer: The Next UK National Cancer Research Network Randomised Trial following HiLo
Open Access
- 30 April 2012
- journal article
- editorial
- Published by Elsevier BV in Clinical Oncology
- Vol. 24 (3), 159-161
- https://doi.org/10.1016/j.clon.2012.01.001
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Use of Radioactive Iodine for Thyroid CancerJAMA, 2011
- Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapyCancer, 2011
- The Revised American Thyroid Association Management Guidelines 2009 for Patients with Differentiated Thyroid Cancer: an Evidence-Based Risk-Adapted ApproachClinical Oncology, 2010
- Contemporary Post Surgical Management of Differentiated Thyroid CarcinomaClinical Oncology, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Recurrence After Treatment of Micropapillary Thyroid CancerThyroid®, 2009
- An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid CancerEndocrinology and Metabolism Clinics of North America, 2008
- Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial TherapyThyroid®, 2006
- Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinomaJournal of Surgical Oncology, 2006
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerAmerican Journal Of Medicine, 1994